Rose-Silverthorne Retinal Degenerations Lab to Conduct Natural History Study of Usher Syndrome
The Rose-Silverthorne Retinal Degenerations Laboratory at the Retina Foundation of the Southwest is beginning a natural history trial to study disease progression of Usher Syndrome Type 2a, a recessive genetic condition affecting nearly 25,000 people in the United States. Usher Syndrome Type 2a is categorized by patients born with mild to moderate hearing loss and vision loss from retinitis pigmentosa. Patients with Usher Syndrome Type 2a have a mutation of the gene USH2A. This study is expected to help us better understand USH2A-related retinal degeneration, develop new treatment options, and evaluate their effectiveness.
Related ArticlesDeveloping a Treatment for Age-Related Macular Degeneration – Video Update Chance Encounter Leads to Early Diagnosis and Treatment for Kate Video Game Software Patented for Age-Related Macular Degeneration Research Discovering New Therapies for AMD National Eye Institute Awards $954,770 for a 5-Year Study on Lazy Eye